These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37179216)

  • 21. Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.
    Chua BH; Link EK; Kunkler IH; Whelan TJ; Westenberg AH; Gruber G; Bryant G; Ahern V; Purohit K; Graham PH; Akra M; McArdle O; O'Brien P; Harvey JA; Kirkove C; Maduro JH; Campbell ID; Delaney GP; Martin JD; Vu TTT; Muanza TM; Neal A; Olivotto IA;
    Lancet; 2022 Aug; 400(10350):431-440. PubMed ID: 35934006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypofractionated whole breast irradiation in association with hypofractionated or normofractionated boost to the tumor bed in early breast cancer: tolerance and efficacy analysis.
    Oses G; Barreto TD; Cases C; Muñoz-Guglielmetti D; Antelo G; Mollà M
    Clin Transl Oncol; 2023 Aug; 25(8):2419-2426. PubMed ID: 36947361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypofractionated radiotherapy with simultaneous tumor bed boost (Hi-RISE) in breast cancer patients receiving upfront breast-conserving surgery: study protocol for a phase III randomized controlled trial.
    Jin K; Luo J; Yu X; Guo X
    Radiat Oncol; 2024 May; 19(1):62. PubMed ID: 38802888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): a non-inferiority, open-label, phase III randomised trial.
    Yadav BS; Dahiya D; Kannan P; Goyal S; Laroiya I; Irrinki S; Singh NR; Sharma R
    Trials; 2024 Jan; 25(1):21. PubMed ID: 38167339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: a multi-centre comparative study.
    Meattini I; Poortmans P; Kirova Y; Saieva C; Visani L; Salvestrini V; Kim J; Jung W; Olmetto E; Mariotti M; Desideri I; Fourquet A; Livi L; Kim K
    Acta Oncol; 2020 Feb; 59(2):188-195. PubMed ID: 31760849
    [No Abstract]   [Full Text] [Related]  

  • 26. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial.
    Wang SL; Fang H; Song YW; Wang WH; Hu C; Liu YP; Jin J; Liu XF; Yu ZH; Ren H; Li N; Lu NN; Tang Y; Tang Y; Qi SN; Sun GY; Peng R; Li S; Chen B; Yang Y; Li YX
    Lancet Oncol; 2019 Mar; 20(3):352-360. PubMed ID: 30711522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypofractionated vs Conventionally Fractionated Postmastectomy Radiation After Implant-Based Reconstruction: A Randomized Clinical Trial.
    Wong JS; Uno H; Tramontano AC; Fisher L; Pellegrini CV; Abel GA; Burstein HJ; Chun YS; King TA; Schrag D; Winer E; Bellon JR; Cheney MD; Hardenbergh P; Ho A; Horst KC; Kim JN; Leonard KL; Moran MS; Park CC; Recht A; Soto DE; Shiloh RY; Stinson SF; Snyder KM; Taghian AG; Warren LE; Wright JL; Punglia RS
    JAMA Oncol; 2024 Oct; 10(10):1370-1378. PubMed ID: 39115975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypofractionated radiation treatment in the management of breast cancer.
    Gupta A; Ohri N; Haffty BG
    Expert Rev Anticancer Ther; 2018 Aug; 18(8):793-803. PubMed ID: 29902386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
    Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
    Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial.
    Krug D; Baumann R; Krockenberger K; Vonthein R; Schreiber A; Boicev A; Würschmidt F; Weinstrauch E; Eilf K; Andreas P; Höller U; Dinges S; Piefel K; Zimmer J; Dellas K; Dunst J
    Strahlenther Onkol; 2021 Jan; 197(1):48-55. PubMed ID: 33001241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of Hypofractionated Versus Conventional Fractionated Postmastectomy Radiation Therapy in Breast Cancer Patients  With Reconstruction.
    Kim DY; Park E; Heo CY; Jin US; Kim EK; Han W; Shin KH; Kim IA
    Int J Radiat Oncol Biol Phys; 2022 Feb; 112(2):445-456. PubMed ID: 34610389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential Moderate Hypofractionated Boost in Breast Cancer Patients: A Monoinstitutional Analysis of Late Side Effects.
    Palumbo I; Becchetti AG; Perrucci E; Falcinelli L; Saldi S; Bini V; Aristei C
    Anticancer Res; 2024 Sep; 44(9):3965-3971. PubMed ID: 39197915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of two radiation boost schedules in postlumpectomy patients with breast cancer.
    Yadav BS; Sharma SC; Singh G; Dahiya D
    J Cancer Res Ther; 2020; 16(6):1344-1349. PubMed ID: 33342794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial.
    Ahlawat S; Haffty BG; Goyal S; Kearney T; Kirstein L; Chen C; Moore DF; Khan AJ
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):118-125. PubMed ID: 26700706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uptake of ultra-hypofractionated radiation therapy following breast-conserving surgery among patients with early-stage breast cancer: a multi-institutional questionnaire survey.
    Uezono H; Onoe T; Shikama N; Ono Y; Hirata H; Ito Y; Yasuda K; Imano N; Kikuchi K; Kashihara T; Kawamoto T; Nakamura N
    Breast Cancer; 2024 Nov; 31(6):1071-1079. PubMed ID: 39046663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial From China.
    Wang SL; Fang H; Hu C; Song YW; Wang WH; Jin J; Liu YP; Ren H; Liu J; Li GF; Du XH; Tang Y; Jing H; Ma YC; Huang Z; Chen B; Tang Y; Li N; Lu NN; Qi SN; Yang Y; Sun GY; Liu XF; Li YX
    J Clin Oncol; 2020 Nov; 38(31):3604-3614. PubMed ID: 32780661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute toxicity of hypofractionated radiotherapy for Japanese breast cancer patients after surgery: a single center prospective observational study (HyPORT-BC).
    Nakamura M; Fujisawa T; Oyoshi H; Zhou Y; Fukushi K; Hirata H; Tomizawa K; Motegi A; Hojo H; Wakabayashi M; Kano K; Ohno R; Nakamura A; Yamaguchi M; Zenda S
    Breast Cancer; 2024 Nov; 31(6):1176-1181. PubMed ID: 39115636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatigue following radiotherapy of low-risk early breast cancer - a randomized controlled trial of intraoperative electron radiotherapy versus standard hypofractionated whole-breast radiotherapy: the COSMOPOLITAN trial (NCT03838419).
    Forster T; Jäkel C; Akbaba S; Krug D; Krempien R; Uhl M; Häfner MF; König L; Koerber SA; Harrabi S; Bernhardt D; Behnisch R; Krisam J; Hennigs A; Sohn C; Heil J; Debus J; Hörner-Rieber J
    Radiat Oncol; 2020 Jun; 15(1):134. PubMed ID: 32487184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protocol for the postoperative radiotherapy in N1 breast cancer patients (PORT-N1) trial, a prospective multicenter, randomized, controlled, non-inferiority trial of patients receiving breast-conserving surgery or mastectomy.
    Lee TH; Chang JH; Jang BS; Kim JS; Kim TH; Park W; Kim YB; Kim SS; Han W; Lee HB; Shin KH
    BMC Cancer; 2022 Nov; 22(1):1179. PubMed ID: 36384573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-institutional phase II study of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for breast cancer in Japan: Kyoto Radiation Oncology Study Group (UPBEAT study).
    Mitsuyoshi T; Ono Y; Ashida R; Yamashita M; Tanabe H; Takebe S; Tokiwa M; Suzuki E; Imagumbai T; Yoshimura M; Yamauchi C; Mizowaki T; Kokubo M
    Jpn J Clin Oncol; 2023 Jan; 53(2):174-178. PubMed ID: 36420578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.